Orth D N, Nicholson W E, Mitchell W M, Island D P, Liddle G W
J Clin Invest. 1973 Jul;52(7):1756-69. doi: 10.1172/JCI107357.
Extracts of tumors from 32 patients with the ectopic ACTH syndrome were subjected to simultaneous bioassay and radioimmunoassays for ACTH. Radioimmunoassays were performed using three antisera, one of which reacts with the extreme N-terminal 1-13 amino acid sequence of ACTH, the second with the N-terminal 1-23 sequence of the ACTH molecule, and the third with the C-terminal 25-39 amino acid sequence of ACTH. There was, in general, good correlation between bioactivity and N-terminal ACTH immunoreactivity. However, there were large excesses of both extreme N-terminal and C-terminal immunoreactive materials in most tumor extracts, which were not found in extracts of three human pituitaries. Three tumor extracts were subjected to molecular sieve chromatography on Sephadex G-50 fine resin. The bioactive ACTH eluted in the same fractions as pituitary ACTH (mol wt approximately 4,500 daltons) and reacted equally in all three ACTH radioimmunoassay systems. The bioactive tumor ACTH was neutralized by incubation with the C-terminal antiserum, indicating it has an intact C-terminal sequence of amino acids. The next several fractions from the Sephadex column contained a material, mol wt approximately 3,100, which was biologically inactive and had C-terminal immunoreactivity but no N-terminal or extreme N-terminal immunoreactivity. Incubation with the N-terminal 1-23 ACTH antiserum did not adsorb these C-terminal fragments, indicating they lacked an intact sequence of amino acids in this region. A smaller ACTH fragment (mol wt approximately 1,800 daltons) eluted in still later fractions and reacted with the extreme N-terminal antiserum but not with the N-terminal or C-terminal antisera. It had no steroidogenic activity, but appeared to have significant melanocyte-stimulating activity. It is concluded that, in addition to an ACTH similar, if not identical, to pituitary ACTH, tumors of patients with the ectopic ACTH syndrome contain both N-terminal and C-terminal ACTH fragments.
对32例异位促肾上腺皮质激素(ACTH)综合征患者的肿瘤提取物进行了ACTH的同步生物测定和放射免疫测定。放射免疫测定使用了三种抗血清,其中一种与ACTH的极端N端1 - 13氨基酸序列反应,第二种与ACTH分子的N端1 - 23序列反应,第三种与ACTH的C端25 - 39氨基酸序列反应。总体而言,生物活性与N端ACTH免疫反应性之间存在良好的相关性。然而,在大多数肿瘤提取物中,极端N端和C端免疫反应性物质都大量过剩,而在三例人垂体提取物中未发现这种情况。对三份肿瘤提取物在Sephadex G - 50细树脂上进行分子筛层析。具有生物活性的ACTH与垂体ACTH在相同的级分中洗脱(分子量约为4500道尔顿),并且在所有三种ACTH放射免疫测定系统中的反应相同。将具有生物活性的肿瘤ACTH与C端抗血清孵育后可被中和,表明它具有完整的C端氨基酸序列。来自Sephadex柱的接下来几个级分含有一种分子量约为3100的物质,它没有生物活性,具有C端免疫反应性,但没有N端或极端N端免疫反应性。与N端1 - 23 ACTH抗血清孵育不会吸附这些C端片段,表明它们在该区域缺乏完整的氨基酸序列。一个较小的ACTH片段(分子量约为1800道尔顿)在更晚的级分中洗脱,与极端N端抗血清反应,但不与N端或C端抗血清反应。它没有类固醇生成活性,但似乎具有显著的促黑素细胞活性。得出的结论是,除了一种与垂体ACTH相似(如果不是相同的话)的ACTH外,异位ACTH综合征患者的肿瘤还含有N端和C端ACTH片段。